FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and pharmacology, namely, to antithrombotic complex based on heparin, which contains high-molecular heparin and glutamic acid in ratio (1±0.3)M of heparin mono-link per (1±0.3)M of glutamic acid, method of its production and use as anticoagulant, anti-platelet, fibrinolytic, fibrin depolymerizing and reducing blood coagulation agent.
EFFECT: group of inventions provides higher output of ready preparation higher its anticoagulant, anti-platelet and fibrinolytic action.
6 cl, 3 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTICOAGULANT, ANTIPLATELET AND FIBRIN-DEPOLYMERIZATION COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2606836C2 |
| ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
| HIGH-MOLECULAR HEPARIN COMPOSITION WITH ANTICOAGULANT, ANTI-PLATELET, FIBRINOLYTIC AND FIBRIN DEPOLYMERISATION PROPERTIES | 2011 |
|
RU2454237C1 |
| HIGH-MOLECULAR HEPARIN COMPOSITION WITH ANTICOAGULANT, ANTI-PLATELET, FIBRINOLYTIC AND FIBRIN DEPOLYMERISATION PROPERTIES | 2011 |
|
RU2456993C1 |
| ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
| ANTI-THROMBOSIS, ANTI-COAGULATING, FIFRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT FOR INTRANASAL ADMINISTRATION | 2005 |
|
RU2290193C1 |
| ANTI-THROMBOSIS, ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, FIBRINOLYTIC AGENT FOR INTRAMUSCULAR ADMINISTRATION | 2005 |
|
RU2288737C1 |
| ANTI-THROMBOSIS, ANTI-COAGULATING, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT | 2005 |
|
RU2290194C1 |
| AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
| ANTITHROMBOSIS AGENT | 1997 |
|
RU2138269C1 |
